sirolimus and saracatinib

In recent years, research has identified the molecular and neural substrates underlying the transition of moderate "social" consumption of alcohol to the characteristic alcohol use disorder (AUD) phenotypes including excessive and compulsive alcohol use which we define in the review as the GO signaling pathways. In addition, growing evidence points to the existence of molecular mechanisms that keep alcohol consumption in check and that confer resilience for the development of AUD which we define herein as the STOP signaling pathways. In this review, we focus on examples of the GO and the STOP intracellular signaling pathways and discuss our current knowledge of how manipulations of these pathways may be used for the treatment of AUD.

Topics: Alcohol Drinking; Alcoholism; Animals; Benzodioxoles; Brain-Derived Neurotrophic Factor; Drug Delivery Systems; Ethanol; Humans; Intracellular Fluid; Quinazolines; Signal Transduction; Sirolimus; Treatment Outcome